Tocqueville Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,000	Closed	-$303K	–	742
2021 Q2	$303K	Sell	5,000 -10	-0.2%	-$633	﹤0.01%	634
2021 Q1	$351K	Hold	5,010	–	–	0.01%	610
2020 Q4	$300K	Sell	5,010 -7	-0.1%	-$410	0.01%	623
2020 Q3	$302K	Buy	5,017 +17	+0.3%	+$988	0.01%	566
2020 Q2	$262K	Buy	+5,000	New	+$209K	0.01%	587
2019 Q3	–	Sell	-4,900	Closed	-$213K	–	778
2019 Q2	$213K	Sell	4,900 -2,000	-29%	-$84.9K	﹤0.01%	736
2019 Q1	$263K	Sell	6,900 -1,100	-14%	-$42.9K	﹤0.01%	694
2018 Q4	$344K	Sell	8,000 -2,000	-20%	-$93.4K	0.01%	610
2018 Q3	$492K	Buy	+10,000	New	+$432K	0.01%	625
2016 Q4	–	Sell	-15,200	Closed	-$520K	–	842
2016 Q3	$520K	Hold	15,200	–	–	0.01%	623
2016 Q2	$513K	Hold	15,200	–	–	0.01%	630
2016 Q1	$805K	Buy	15,200 +3,300	+28%	+$193K	0.01%	535
2015 Q4	$914K	Buy	+11,900	New	+$674K	0.01%	559
2015 Q3	–	Sell	-12,750	Closed	-$902K	–	997
2015 Q2	$902K	Sell	12,750 -2,530	-17%	-$199K	0.01%	589
2015 Q1	$1.36M	Buy	15,280 +1,780	+13%	+$181K	0.02%	535
2014 Q4	$1.2M	Buy	+13,500	New	+$1.28M	0.01%	548